speb/financial-data huggingface dataset:
OCUL balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 0.00
OCUL balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 49294000.00
OCUL cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1069000.00
OCUL cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1069000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 14962000.00
OCUL income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 183919808.00
OCUL income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.38
OCUL income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -69418000.00
OCUL income_statement (quarterly, 2025-09-30) — EBIT: -66416000.00
OCUL income_statement (quarterly, 2025-09-30) — EBITDA: -65347000.00
OCUL cash_flow (quarterly, 2025-09-30) — End Cash Position: 346386000.00
OCUL cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 10356000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Finished Goods: 1900000.00
OCUL cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -56718000.00
OCUL cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 1447000.00
OCUL cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
OCUL income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 0.00
OCUL income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -1447000.00
OCUL income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 27672000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Gross PPE: 22288000.00
OCUL income_statement (quarterly, 2025-09-30) — Gross Profit: 12770000.00
OCUL income_statement (quarterly, 2025-09-30) — Interest Expense: 3002000.00
OCUL income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 3002000.00
OCUL income_statement (quarterly, 2025-09-30) — Interest Income: 3729000.00
OCUL income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 3729000.00
OCUL cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 2337000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Interest Payable: 733000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Inventory: 3488000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Invested Capital: 328846000.00
OCUL cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -5993000.00
OCUL cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
OCUL balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 3629000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 70617000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 74246000.00
OCUL cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
OCUL income_statement (quarterly, 2025-09-30) — Net Income: -69418000.00
OCUL income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -69418000.00
OCUL income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -69418000.00
OCUL income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -69418000.00
OCUL income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -69418000.00
OCUL cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -69418000.00
OCUL income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -69418000.00
OCUL income_statement (quarterly, 2025-09-30) — Net Interest Income: 727000.00
OCUL income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 727000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Net PPE: 22288000.00
OCUL cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -5993000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 258229000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 14000000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 14000000.00
OCUL income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -63900000.00
OCUL income_statement (quarterly, 2025-09-30) — Normalized Income: -67971000.00
OCUL cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -50725000.00
OCUL cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 1447000.00
OCUL income_statement (quarterly, 2025-09-30) — Operating Income: -68698000.00
OCUL income_statement (quarterly, 2025-09-30) — Operating Revenue: 14544000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 174949558.00
OCUL balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 7952000.00
OCUL income_statement (quarterly, 2025-09-30) — Other Gand A: 8329000.00
OCUL income_statement (quarterly, 2025-09-30) — Other Income Expense: -1447000.00
OCUL cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 758000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1614000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 151000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Other Properties: 22288000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Payables: 6260000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 46532000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
OCUL income_statement (quarterly, 2025-09-30) — Pretax Income: -69418000.00
OCUL cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 10356000.00
OCUL cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -5993000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Raw Materials: 229000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Receivables: 30768000.00
OCUL income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1774000.00
OCUL income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1069000.00
OCUL income_statement (quarterly, 2025-09-30) — Research And Development: 52358000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1092369000.00
OCUL income_statement (quarterly, 2025-09-30) — Salaries And Wages: 19343000.00
OCUL cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
OCUL income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1438000.00
OCUL income_statement (quarterly, 2025-09-30) — Selling General And Administration: 29110000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Share Issued: 174949558.00
OCUL income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
OCUL cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 11691000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 258229000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 258229000.00
OCUL income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
OCUL income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
OCUL balance_sheet (quarterly, 2025-09-30) — Total Assets: 410882000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 328846000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Total Debt: 77008000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 258229000.00
OCUL income_statement (quarterly, 2025-09-30) — Total Expenses: 83242000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 152653000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 23902000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 103359000.00
OCUL income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -68698000.00
OCUL income_statement (quarterly, 2025-09-30) — Total Unusual Items: -1447000.00
OCUL income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -1447000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Work In Process: 1359000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Working Capital: 337686000.00
OCUL income_statement (annual, 2025-12-31) — +Operating Expense: 315394000.00
OCUL income_statement (quarterly, 2025-12-31) — +Operating Expense: 81416000.00
OCUL income_statement (annual, 2025-12-31) — +Total Revenue: 51951000.00
OCUL income_statement (quarterly, 2025-12-31) — +Total Revenue: 13250000.00
OCUL balance_sheet (annual, 2025-12-31) — Accounts Payable: 4154000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4154000.00
OCUL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 30650000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 30650000.00
OCUL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -27520000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -27520000.00
OCUL balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1811311000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1811311000.00
OCUL income_statement (annual, 2025-12-31) — Basic Average Shares: 187241483.00
OCUL income_statement (quarterly, 2025-12-31) — Basic Average Shares: 222921325.00
OCUL income_statement (annual, 2025-12-31) — Basic EPS: -1.42
OCUL income_statement (quarterly, 2025-12-31) — Basic EPS: -0.29
OCUL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 393716000.00
OCUL cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 346386000.00
OCUL cash_flow (annual, 2025-12-31) — Capital Expenditure: -12010000.00
OCUL cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -2839000.00
OCUL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 5632000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 5632000.00
OCUL balance_sheet (annual, 2025-12-31) — Capital Stock: 22000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 22000.00
OCUL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 737060000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 737060000.00
OCUL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 737060000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 737060000.00
OCUL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 561721000.00
OCUL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 449376000.00
OCUL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11880000.00
OCUL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2839000.00
OCUL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -204883000.00
OCUL cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -54249000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Account Payable: -887000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1353000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 5248000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 2176000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Inventory: -524000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Inventory: -76000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 1307000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 696000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1646000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -759000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -128000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 0.00
OCUL cash_flow (annual, 2025-12-31) — Change In Payable: -887000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Payable: -1353000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 4361000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 823000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 2602000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -2903000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Receivables: 1738000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Receivables: 118000.00
OCUL cash_flow (annual, 2025-12-31) — Change In Working Capital: 7710000.00
OCUL cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -2101000.00
OCUL cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1738000.00
OCUL cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 118000.00
OCUL cash_flow (annual, 2025-12-31) — Changes In Cash: 344958000.00
OCUL cash_flow (quarterly, 2025-12-31) — Changes In Cash: 392288000.00
OCUL balance_sheet (annual, 2025-12-31) — Common Stock: 22000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Common Stock: 22000.00
OCUL balance_sheet (annual, 2025-12-31) — Common Stock Equity: 654310000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 654310000.00
OCUL cash_flow (annual, 2025-12-31) — Common Stock Issuance: 541177000.00
OCUL cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 446439000.00
OCUL balance_sheet (annual, 2025-12-31) — Construction In Progress: 10256000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 10256000.00
OCUL income_statement (annual, 2025-12-31) — Cost Of Revenue: 6574000.00
OCUL income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1594000.00
OCUL balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 43835000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 43835000.00
OCUL balance_sheet (annual, 2025-12-31) — Current Assets: 782129000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Current Assets: 782129000.00
OCUL balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 2817000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2817000.00
OCUL balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 2817000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2817000.00
OCUL balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 0.00
OCUL balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 0.00
OCUL balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 0.00
OCUL balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 0.00
OCUL balance_sheet (annual, 2025-12-31) — Current Liabilities: 50806000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 50806000.00
OCUL cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 4323000.00
OCUL cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1247000.00
OCUL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 4323000.00
OCUL cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1247000.00
OCUL balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 13903000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 13903000.00
OCUL income_statement (annual, 2025-12-31) — Diluted Average Shares: 187241483.00
OCUL income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 222921325.00
OCUL income_statement (annual, 2025-12-31) — Diluted EPS: -1.42
OCUL income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.29
OCUL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -265939000.00
OCUL income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -64654000.00
OCUL income_statement (annual, 2025-12-31) — EBIT: -254104000.00
OCUL income_statement (quarterly, 2025-12-31) — EBIT: -61822000.00
OCUL income_statement (annual, 2025-12-31) — EBITDA: -249781000.00
OCUL income_statement (quarterly, 2025-12-31) — EBITDA: -60575000.00
OCUL cash_flow (annual, 2025-12-31) — End Cash Position: 738674000.00
OCUL cash_flow (quarterly, 2025-12-31) — End Cash Position: 738674000.00
OCUL cash_flow (annual, 2025-12-31) — Financing Cash Flow: 561721000.00
OCUL cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 449376000.00
OCUL balance_sheet (annual, 2025-12-31) — Finished Goods: 1641000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1641000.00
OCUL cash_flow (annual, 2025-12-31) — Free Cash Flow: -216893000.00
OCUL cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -57088000.00
OCUL cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 2471000.00
OCUL cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -595000.00
OCUL cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -29000.00
OCUL cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
OCUL income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -2471000.00
OCUL income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 595000.00
OCUL income_statement (annual, 2025-12-31) — General And Administrative Expense: 112150000.00
OCUL income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 28986000.00
OCUL balance_sheet (annual, 2025-12-31) — Gross PPE: 51834000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Gross PPE: 51834000.00
OCUL income_statement (annual, 2025-12-31) — Gross Profit: 45377000.00
OCUL income_statement (quarterly, 2025-12-31) — Gross Profit: 11656000.00
OCUL income_statement (annual, 2025-12-31) — Interest Expense: 11835000.00
OCUL income_statement (quarterly, 2025-12-31) — Interest Expense: 2832000.00
OCUL income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 11835000.00
OCUL income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2832000.00
OCUL income_statement (annual, 2025-12-31) — Interest Income: 18355000.00
OCUL income_statement (quarterly, 2025-12-31) — Interest Income: 7343000.00
OCUL income_statement (annual, 2025-12-31) — Interest Income Non Operating: 18355000.00
OCUL income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 7343000.00
OCUL cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 9029000.00
OCUL cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 2244000.00
OCUL balance_sheet (annual, 2025-12-31) — Interest Payable: 754000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Interest Payable: 754000.00
OCUL balance_sheet (annual, 2025-12-31) — Inventory: 3564000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Inventory: 3564000.00
OCUL balance_sheet (annual, 2025-12-31) — Invested Capital: 725646000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Invested Capital: 725646000.00
OCUL cash_flow (annual, 2025-12-31) — Investing Cash Flow: -11880000.00
OCUL cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2839000.00
OCUL cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 541177000.00
OCUL cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 446439000.00
OCUL cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
OCUL balance_sheet (annual, 2025-12-31) — Leases: 15280000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Leases: 15280000.00
OCUL balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2815000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2815000.00
OCUL balance_sheet (annual, 2025-12-31) — Long Term Debt: 71336000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 71336000.00
OCUL balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 74151000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 74151000.00
OCUL cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
OCUL cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
OCUL balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1598000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1598000.00
OCUL cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 541177000.00
OCUL cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 446439000.00
OCUL income_statement (annual, 2025-12-31) — Net Income: -265939000.00
OCUL income_statement (quarterly, 2025-12-31) — Net Income: -64654000.00
OCUL income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -265939000.00
OCUL income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -64654000.00
OCUL income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -265939000.00
OCUL income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -64654000.00
OCUL income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -265939000.00
OCUL income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -64654000.00
OCUL income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -265939000.00
OCUL income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -64654000.00
OCUL cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -265939000.00
OCUL cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -64654000.00
OCUL income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -265939000.00
OCUL income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -64654000.00
OCUL income_statement (annual, 2025-12-31) — Net Interest Income: 6520000.00
OCUL income_statement (quarterly, 2025-12-31) — Net Interest Income: 4511000.00
OCUL cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
OCUL cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
OCUL income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 6520000.00
OCUL income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 4511000.00
OCUL balance_sheet (annual, 2025-12-31) — Net PPE: 24314000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Net PPE: 24314000.00
OCUL cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -11880000.00
OCUL cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -2839000.00
OCUL cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
OCUL balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 654310000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 654310000.00
OCUL balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 14000000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 14000000.00
OCUL balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 14000000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 14000000.00
OCUL income_statement (annual, 2025-12-31) — Normalized EBITDA: -247310000.00
OCUL income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -61141000.00
OCUL income_statement (annual, 2025-12-31) — Normalized Income: -263468000.00
OCUL income_statement (quarterly, 2025-12-31) — Normalized Income: -65220000.00
OCUL cash_flow (annual, 2025-12-31) — Operating Cash Flow: -204883000.00
OCUL cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -54249000.00
OCUL cash_flow (annual, 2025-12-31) — Operating Gains Losses: 2442000.00
OCUL cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -595000.00
OCUL income_statement (annual, 2025-12-31) — Operating Income: -270017000.00
OCUL income_statement (quarterly, 2025-12-31) — Operating Income: -69760000.00
OCUL income_statement (annual, 2025-12-31) — Operating Revenue: 51951000.00
OCUL income_statement (quarterly, 2025-12-31) — Operating Revenue: 13250000.00
OCUL balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 215927600.00
OCUL balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 215927600.00
OCUL balance_sheet (annual, 2025-12-31) — Other Current Assets: 10855000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 10855000.00
OCUL income_statement (annual, 2025-12-31) — Other Gand A: 35408000.00
OCUL income_statement (quarterly, 2025-12-31) — Other Gand A: 8758000.00
OCUL income_statement (annual, 2025-12-31) — Other Income Expense: -2442000.00
OCUL income_statement (quarterly, 2025-12-31) — Other Income Expense: 595000.00
OCUL cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3397000.00
OCUL cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 495000.00
OCUL balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1614000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1614000.00
OCUL balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 887000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 887000.00
OCUL income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 29000.00
OCUL balance_sheet (annual, 2025-12-31) — Other Properties: 24700000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Other Properties: 24700000.00
OCUL balance_sheet (annual, 2025-12-31) — Payables: 4154000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Payables: 4154000.00
OCUL balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 47989000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 47989000.00
OCUL balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
OCUL balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
OCUL income_statement (annual, 2025-12-31) — Pretax Income: -265939000.00
OCUL income_statement (quarterly, 2025-12-31) — Pretax Income: -64654000.00
OCUL cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 20544000.00
OCUL cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 2937000.00
OCUL balance_sheet (annual, 2025-12-31) — Properties: 0.00
OCUL balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
OCUL cash_flow (annual, 2025-12-31) — Purchase Of PPE: -12010000.00
OCUL cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -2839000.00
OCUL balance_sheet (annual, 2025-12-31) — Raw Materials: 202000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Raw Materials: 202000.00
OCUL balance_sheet (annual, 2025-12-31) — Receivables: 30650000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Receivables: 30650000.00
OCUL income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 6574000.00
OCUL income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1594000.00
OCUL income_statement (annual, 2025-12-31) — Reconciled Depreciation: 4323000.00
OCUL income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1247000.00
OCUL cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
OCUL income_statement (annual, 2025-12-31) — Research And Development: 197096000.00
OCUL income_statement (quarterly, 2025-12-31) — Research And Development: 50800000.00
OCUL balance_sheet (annual, 2025-12-31) — Retained Earnings: -1157023000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1157023000.00
OCUL income_statement (annual, 2025-12-31) — Salaries And Wages: 76742000.00
OCUL income_statement (quarterly, 2025-12-31) — Salaries And Wages: 20228000.00
OCUL cash_flow (annual, 2025-12-31) — Sale Of PPE: 130000.00
OCUL cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
OCUL income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 6148000.00
OCUL income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1630000.00
OCUL income_statement (annual, 2025-12-31) — Selling General And Administration: 118298000.00
OCUL income_statement (quarterly, 2025-12-31) — Selling General And Administration: 30616000.00
OCUL balance_sheet (annual, 2025-12-31) — Share Issued: 215927600.00
OCUL balance_sheet (quarterly, 2025-12-31) — Share Issued: 215927600.00
OCUL cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
OCUL cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
OCUL income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
OCUL income_statement (quarterly, 2025-12-31) — Special Income Charges: -29000.00
OCUL cash_flow (annual, 2025-12-31) — Stock Based Compensation: 43184000.00
OCUL cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 11359000.00
OCUL balance_sheet (annual, 2025-12-31) — Stockholders Equity: 654310000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 654310000.00
OCUL balance_sheet (annual, 2025-12-31) — Tangible Book Value: 654310000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 654310000.00
OCUL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
OCUL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
OCUL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
OCUL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
OCUL balance_sheet (annual, 2025-12-31) — Total Assets: 808057000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Total Assets: 808057000.00
OCUL balance_sheet (annual, 2025-12-31) — Total Capitalization: 725646000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 725646000.00
OCUL balance_sheet (annual, 2025-12-31) — Total Debt: 76968000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Total Debt: 76968000.00
OCUL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 654310000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 654310000.00
OCUL income_statement (annual, 2025-12-31) — Total Expenses: 321968000.00
OCUL income_statement (quarterly, 2025-12-31) — Total Expenses: 83010000.00
OCUL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 153747000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 153747000.00
OCUL balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 25928000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 25928000.00
OCUL balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 102941000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 102941000.00
OCUL income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -270017000.00
OCUL income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -69760000.00
OCUL income_statement (annual, 2025-12-31) — Total Unusual Items: -2471000.00
OCUL income_statement (quarterly, 2025-12-31) — Total Unusual Items: 566000.00
OCUL income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2471000.00
OCUL income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 566000.00
OCUL balance_sheet (annual, 2025-12-31) — Work In Process: 1721000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Work In Process: 1721000.00
OCUL balance_sheet (annual, 2025-12-31) — Working Capital: 731323000.00
OCUL balance_sheet (quarterly, 2025-12-31) — Working Capital: 731323000.00
OCUL income_statement (quarterly, 2026-03-31) — +Operating Expense: 102796000.00
OCUL income_statement (quarterly, 2026-03-31) — +Total Revenue: 10785000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8026000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 24347000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1827187000.00
OCUL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 224099410.00
OCUL income_statement (quarterly, 2026-03-31) — Basic EPS: -0.40
OCUL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 738674000.00
OCUL cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4662000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 7400000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 22000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 666699000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 666699000.00
OCUL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 294000.00
OCUL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -4662000.00
OCUL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -65993000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 3719000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -8441000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Inventory: -173000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -1857000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 1768000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Payable: 3719000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -4722000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -357000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Receivables: 6303000.00
OCUL cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 962000.00
OCUL cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 6303000.00
OCUL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -70361000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Common Stock: 22000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 581574000.00
OCUL income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1329000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 36487000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Current Assets: 705995000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3170000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3170000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 47683000.00
OCUL cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1283000.00
OCUL cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1283000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 12071000.00
OCUL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 224099410.00
OCUL income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.40
OCUL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -88612000.00
OCUL income_statement (quarterly, 2026-03-31) — EBIT: -85835000.00
OCUL income_statement (quarterly, 2026-03-31) — EBITDA: -84552000.00
OCUL cash_flow (quarterly, 2026-03-31) — End Cash Position: 668313000.00
OCUL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 294000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Finished Goods: 2208000.00
OCUL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -70655000.00
OCUL cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -1455000.00
OCUL cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 4866000.00
OCUL income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 1455000.00
OCUL income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 20006000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Gross PPE: 24920000.00
OCUL income_statement (quarterly, 2026-03-31) — Gross Profit: 9456000.00
OCUL income_statement (quarterly, 2026-03-31) — Interest Expense: 2777000.00
OCUL income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2777000.00
OCUL income_statement (quarterly, 2026-03-31) — Interest Income: 6050000.00
OCUL income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 6050000.00
OCUL cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 2189000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Interest Payable: 716000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Inventory: 3737000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 653636000.00
OCUL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -4662000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 4230000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 72062000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 76292000.00
OCUL income_statement (quarterly, 2026-03-31) — Net Income: -88612000.00
OCUL income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -88612000.00
OCUL income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -88612000.00
OCUL income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -88612000.00
OCUL income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -88612000.00
OCUL cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -88612000.00
OCUL income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -88612000.00
OCUL income_statement (quarterly, 2026-03-31) — Net Interest Income: 3273000.00
OCUL income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 3273000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Net PPE: 24920000.00
OCUL cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -4662000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 581574000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 14000000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 14000000.00
OCUL income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -86007000.00
OCUL income_statement (quarterly, 2026-03-31) — Normalized Income: -90067000.00
OCUL cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -65993000.00
OCUL cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 3411000.00
OCUL income_statement (quarterly, 2026-03-31) — Operating Income: -93340000.00
OCUL income_statement (quarterly, 2026-03-31) — Operating Revenue: 10785000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 218896915.00
OCUL balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 11212000.00
OCUL income_statement (quarterly, 2026-03-31) — Other Gand A: 20006000.00
OCUL income_statement (quarterly, 2026-03-31) — Other Income Expense: 1455000.00
OCUL cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1381000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1614000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 909000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Other Properties: 24920000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Payables: 8026000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 44513000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
OCUL income_statement (quarterly, 2026-03-31) — Pretax Income: -88612000.00
OCUL cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 294000.00
OCUL cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4662000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Raw Materials: 287000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Receivables: 24347000.00
OCUL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1329000.00
OCUL income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1283000.00
OCUL income_statement (quarterly, 2026-03-31) — Research And Development: 66213000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1245635000.00
OCUL income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 16577000.00
OCUL income_statement (quarterly, 2026-03-31) — Selling General And Administration: 36583000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Share Issued: 218896915.00
OCUL cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 15582000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 581574000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 581574000.00
OCUL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
OCUL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
OCUL balance_sheet (quarterly, 2026-03-31) — Total Assets: 732529000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 653636000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Total Debt: 79462000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 581574000.00
OCUL income_statement (quarterly, 2026-03-31) — Total Expenses: 104125000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 150955000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 26534000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 103272000.00
OCUL income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -93340000.00
OCUL income_statement (quarterly, 2026-03-31) — Total Unusual Items: 1455000.00
OCUL income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1455000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Work In Process: 1242000.00
OCUL balance_sheet (quarterly, 2026-03-31) — Working Capital: 658312000.00
OD6.AX income_statement (annual, 2022-06-30) — +Operating Expense: 1339658.00
OD6.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 427697.00
OD6.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 39698995.00
OD6.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.03
OD6.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -658908.00
OD6.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -493988.00
OD6.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 9224855.00
OD6.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 8357053.00
OD6.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 8357053.00
OD6.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 8357053.00
OD6.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 9506112.00
OD6.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -658908.00
OD6.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -490151.00
OD6.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 8357053.00
OD6.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -490610.00
OD6.AX balance_sheet (annual, 2022-06-30) — Common Stock: 9224855.00
OD6.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 8722334.00
OD6.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 9879554.00
OD6.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -68738.00
OD6.AX balance_sheet (annual, 2022-06-30) — Current Assets: 8522313.00
OD6.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 670195.00
OD6.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 8193.00
OD6.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 1818.00
OD6.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 1818.00
OD6.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 1818.00
OD6.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 39698995.00
OD6.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.03
OD6.AX income_statement (annual, 2022-06-30) — EBIT: -1339658.00
OD6.AX income_statement (annual, 2022-06-30) — EBITDA: -1337840.00
OD6.AX cash_flow (annual, 2022-06-30) — End Cash Position: 8357053.00
OD6.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 9506112.00
OD6.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -1149059.00
OD6.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 865953.00
OD6.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 816007.00
OD6.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 870216.00
OD6.AX income_statement (annual, 2022-06-30) — Interest Income: 459.00
OD6.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 459.00
OD6.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 459.00
OD6.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 8722334.00
OD6.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -658908.00
OD6.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 9879554.00
OD6.AX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -304704.00
OD6.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 163102.00
OD6.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 9810816.00
OD6.AX income_statement (annual, 2022-06-30) — Net Income: -1339199.00
OD6.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -1339199.00
OD6.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -1339199.00
OD6.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -1339199.00
OD6.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -1339199.00
OD6.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -1339199.00
OD6.AX income_statement (annual, 2022-06-30) — Net Interest Income: 459.00
OD6.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -304704.00
OD6.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -304704.00
OD6.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: 459.00
OD6.AX balance_sheet (annual, 2022-06-30) — Net PPE: 870216.00
OD6.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -164920.00
OD6.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 8722334.00
OD6.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -1337840.00
OD6.AX income_statement (annual, 2022-06-30) — Normalized Income: -1339199.00
OD6.AX income_statement (annual, 2022-06-30) — Operating Income: -1339658.00
OD6.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 102450745.00
OD6.AX balance_sheet (annual, 2022-06-30) — Other Current Assets: 165260.00
OD6.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 865953.00
OD6.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 521833.00
OD6.AX balance_sheet (annual, 2022-06-30) — Other Payable: 234305.00
OD6.AX balance_sheet (annual, 2022-06-30) — Other Properties: 707114.00
OD6.AX balance_sheet (annual, 2022-06-30) — Payables: 662002.00
OD6.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 662002.00
OD6.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -490610.00
OD6.AX income_statement (annual, 2022-06-30) — Pretax Income: -1339199.00
OD6.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -164920.00
OD6.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 1818.00
OD6.AX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -304704.00
OD6.AX cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -68738.00
OD6.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -1368474.00
OD6.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 816007.00
OD6.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 816007.00
OD6.AX balance_sheet (annual, 2022-06-30) — Share Issued: 102450745.00
OD6.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 8722334.00
OD6.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 8722334.00
OD6.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
OD6.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
OD6.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
OD6.AX balance_sheet (annual, 2022-06-30) — Total Assets: 9392529.00
OD6.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 8722334.00
OD6.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 8722334.00
OD6.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 670195.00
OD6.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 870216.00
OD6.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
OD6.AX balance_sheet (annual, 2022-06-30) — Working Capital: 7852118.00